Drug
Famitinib malate clinical trials
A product of Famitinib; its studies count on that page too.
Keep track of what changes. Save the Famitinib malate studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Combined with it in one product
Studies by the year they started
7 studies that test it; most in 2026 (2)
| Year | Studies |
|---|---|
| 2009 | 1 |
| 2012 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2026 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 4 · Other 3
Jiangsu HengRui Medicine Co., Ltd. (4) · Fudan University (1) · Hunan Cancer Hospital (1) · The First Affiliated Hospital with Nanjing Medical University (1)
Often tested with
Tested in the same studies.
Camrelizumab (2) · Antineoplastic Agents (1) · SHR-1701 (1) · Gemcitabine (1) · Oxaliplatin (1) · Paclitaxel (1)
Studies
Open first, then newest update. How each study uses Famitinib malate is read from its arms, and is right about nine times in ten.
Testing it · 7
- Perioperative Retlirafusp Alfa(Anti-PD-L1/TGF-β Bifunctional Fusion Protein) Plus Famitinib and GEMOX-Based Hepatic Arterial Infusion Chemotherapy for Locally Advanced Intrahepatic Cholangiocarcinoma: A Multicenter, Single-Arm, Exploratory Phase II TrialRecruitingPhase 2The First Affiliated Hospital with Nanjing Medical UniversityNCT07847710Written as Famitinib malate
- Camrelizumab Combined With Famitinib Malate and Chemotherapy for Treatment of Recurrent/ Metastatic Cervical CancerNot yet recruitingPhase 2Hunan Cancer HospitalNCT07627620Written as Famitinib Malate
- Pharmacokinetics Study of Famitinib Malate Capsules in Healthy SubjectsCompletedPhase 1Jiangsu HengRui Medicine Co., Ltd.NCT05046808Written as Famitinib Malate Capsules
- A Trial of Camrelizumab for Injection in Combination With Famitinib Malate Capsule and Paclitaxel For Injection(Albumin Bound) in Advanced Solid Tumors of PatientsStatus unknownPhase 2Jiangsu HengRui Medicine Co., Ltd.NCT05214976Written as Camrelizumab for Injection, Famitinib malate capsule, Paclitaxel For Injection(Albumin Bound)
- A Bioequivalence Study of Famitinib Malate on Healthy Chinese VolunteersCompletedPhase 1Jiangsu HengRui Medicine Co., Ltd.NCT04400123Written as Famitinib malate
- A Phase I Study of Famitinib Malate in Patients With Solid TumorCompletedPhase 1Jiangsu HengRui Medicine Co., Ltd.NCT01762280Written as Famitinib Malate Capsule
- A Study of Famitinib Malate in HER2-negative Metastatic Breast CancerCompletedPhase 2Fudan UniversityNCT01653574Written as Famitinib Malate
Codes
What other systems call Famitinib malate · ClinicalTrials.gg INT014921
- UNII (FDA) 4RST0F28MRFAMITINIB L-MALATEConfirmed FDA, Wikidata
- Wikidata Q83022178Famitinib malateConfirmed FDA, Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 4RST0F28MR | FAMITINIB L-MALATE | Confirmed FDA, Wikidata |
| Wikidata | Q83022178 | Famitinib malate | Confirmed FDA, Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.